Bharti V, Tan H, Zhou H, Wang JF (2019) Txnip mediates glucocorticoid-activated NLRP3 inflammatory signaling in mouse microglia. Neurochem Int 131:104564

Article  CAS  PubMed  Google Scholar 

Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L (2018) Development of azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer’s Disease. J Prev Alzheim 5(2):149–154

CAS  Google Scholar 

Cai Z, Liu N, Wang C, Qin B, Zhou Y, Xiao M, Chang L, Yan LJ, Zhao B (2016) Role of RAGE in Alzheimer’s Disease. Cell Mol Neurobiol 36(4):483–495

Article  CAS  PubMed  Google Scholar 

Choi BR, Cho WH, Kim J, Lee HJ, Chung C, Jeon WK, Han JS (2014) Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease. Exp Mol Med 46(2):e75

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cuevas E, Lantz SM, Tobón-Velasco JC, Newport GD, Wu Q, Virmani A, Ali SF, Santamaría A (2011) On the in vivo early toxic properties of A-beta 25–35 peptide in the rat hippocampus: involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression. Neurotoxicol Teratol 33(2):288–296

Article  CAS  PubMed  Google Scholar 

Cui L, Cai Y, Cheng W, Liu G, Zhao J, Cao H, Tao H, Wang Y, Yin M, Liu T, Liu Y, Huang P, Liu Z, Li K, Zhao B (2017) A novel, multi-target natural drug candidate, matrine, improves cognitive deficits in Alzheimer’s Disease transgenic mice by inhibiting aβ aggregation and blocking the RAGE/Aβ Axis. Mol Neurobiol 54(3):1939–1952

Article  CAS  PubMed  Google Scholar 

Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ, Thiyagarajan M, Zarcone T, Fritz G, Friedman AE, Miller BL, Zlokovic BV (2012) A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Investig 122(4):1377–1392

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding B, Lin C, Liu Q, He Y, Ruganzu JB, Jin H, Peng X, Ji S, Ma Y, Yang W (2020) Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro. J Neuroinflamm 17(1):302

Article  Google Scholar 

Dong H, Zhang Y, Huang Y, Deng H (2022) Pathophysiology of RAGE in inflammatory diseases. Front Immunol 13:931473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dubey H, Gulati K, Ray A (2018a) Recent studies on cellular and molecular mechanisms in Alzheimer’s disease: focus on epigenetic factors and histone deacetylase. Rev Neurosci 29(3):241–260

Article  CAS  PubMed  Google Scholar 

Dubey H, Gulati K, Ray A (2018b) Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer’s disease in rats. Neurotoxicology 66:58–65

Article  CAS  PubMed  Google Scholar 

Dubey H, Dubey A, Gulati K, Ray A (2022) Protective effects of L-arginine on cognitive deficits and biochemical parameters in an experimental model of type-2 diabetes mellitus induced Alzheimer's disease in rats. J Physiol Pharmacol 73(1)

Dubey H, Roychoudhury R, Alex A, Best C, Liu S, White A, Carlson A, Azcarate-Peril MA, Mansfield LS, Knickmeyer R (2023) Effect of Human Infant Gut Microbiota on Mouse Behavior, Dendritic Complexity, and Myelination. bioRxiv [Preprint]

Fang F, Yu Q, Arancio O, Chen D, Gore SS, Yan SS, Yan SF (2018) RAGE mediates Abeta accumulation in a mouse model of Alzheimer’s disease via modulation of beta- and gamma-secretase activity. Hum Mol Genet 27(6):1002–1014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fertan E, Rodrigues GJ, Wheeler RV, Goguen D, Wong AA, James H, Stadnyk A, Brown RE, Weaver ICG (2019) Cognitive decline, cerebral-spleen tryptophan metabolism, oxidative stress, cytokine production, and regulation of the txnip gene in a triple transgenic mouse model of Alzheimer Disease. Am J Pathol 189(7):1435–1450

Article  CAS  PubMed  Google Scholar 

Finneran DJ, Nash KR (2019) Neuroinflammation and fractalkine signaling in Alzheimer’s disease. J Neuroinflamm 16(1):30

Article  Google Scholar 

GBD (2019) Dementia Forecasting Collaborators (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):e105–e125

Google Scholar 

Guan L, Mao Z, Yang S, Wu G, Chen Y, Yin L, Qi Y, Han L, Xu L (2022) Dioscin alleviates Alzheimer’s disease through regulating RAGE/NOX4 mediated oxidative stress and inflammation. Biomed Pharmacother 152:113248

Article  CAS  PubMed  Google Scholar 

Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The Amyloid-β Pathway in Alzheimer’s Disease. Mol Psychiatry 26(10):5481–5503

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han YT, Choi GI, Son D, Kim NJ, Yun H, Lee S, Chang DJ, Hong HS, Kim H, Ha HJ, Kim YH, Park HJ, Lee J, Suh YG (2012) Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors. J Med Chem 55(21):9120–9135

Article  CAS  PubMed  Google Scholar 

Han YT, Kim K, Son D, An H, Kim H, Lee J, Park HJ, Lee J, Suh YG (2015) Fine tuning of 4,6-bisphenyl-2-(3-alkoxyanilino)pyrimidine focusing on the activity-sensitive aminoalkoxy moiety for a therapeutically useful inhibitor of receptor for advanced glycation end products (RAGE). Bioorg Med Chem 23(3):579–587

Article  CAS  PubMed  Google Scholar 

Hong Y, Shen C, Yin Q, Sun M, Ma Y, Liu X (2016) Effects of RAGE-specific inhibitor FPS-ZM1 on amyloid-β metabolism and ages-induced inflammation and oxidative stress in rat hippocampus. Neurochem Res 41(5):1192–1199

Article  CAS  PubMed  Google Scholar 

Huang YY, Fang N, Luo HR, Gao F, Zou Y, Zhou LL, Zeng QP, Fang SS, Xiao F, Zheng Q (2020) RP1, a RAGE antagonist peptide, can improve memory impairment and reduce Aβ plaque load in the APP/PS1 mouse model of Alzheimer’s disease. Neuropharmacology 180:108304

Article  CAS  PubMed  Google Scholar 

Hudson BI, Lippman ME (2018) Targeting RAGE signaling in inflammatory disease. Ann Rev Med 69:349–364

Article  CAS  PubMed  Google Scholar 

Hudson BI, Kalea AZ, Del Mar AM, Harja E, Boulanger E, D’Agati V, Schmidt AM (2008) Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem 283(49):34457–34468

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishihara K, Tsutsumi K, Kawane S, Nakajima M, Kasaoka T (2003) The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Letter 550:107–113

Article  CAS  Google Scholar 

Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Zhao L, Jin H, Xu H, Wang F, Zhou A, Zuo X, Wu L, Han HY, Huang L, Wang Q, Li D, Chu C, Shi L, Gong M, Du Y, Zhang J, Zhang J, Zhou C, Lv J, Lv Y, Xie H, Ji Y, Li F, Yu E, Luo B, Wang Y, Yang S, Qu Q, Guo Q, Liang F, Zhang J, Tan L, Shen L, Zhang K, Zhang J, Peng D, Tang M, Lv P, Fang B, Chu L, Jia L, Gauthier S (2018) The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement 14(4):483–491

Article  PubMed  Google Scholar 

Jorfi M, Maaser-Hecker A, Tanzi RE (2023) The neuroimmune axis of Alzheimer’s disease. Genome Med 15(1):6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalea AZ, Schmidt AM, Hudson BI (2009) RAGE: a novel biological and genetic marker for vascular disease. Clin Sci 116(8):621–637

Article  CAS  Google Scholar 

Kierdorf K, Fritz G (2013) RAGE regulation and signaling in inflammation and beyond. J Leukocyte Biol 94(1):55–68

Article  CAS  PubMed  Google Scholar 

Kim HY, Lee DK, Chung BR, Kim HV, Kim Y (2016) Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits. J vis Exp 16(109):53308

Google Scholar 

Li L, Ismael S, Nasoohi S, Sakata K, Liao FF, McDonald MP, Ishrat T (2019) Thioredoxin-interacting protein (TXNIP) associated nlrp3 inflammasome activation in human alzheimer’s disease brain. J Alzheimers Dis 68(1):255–265

Article